Validation of Treatment Strategies for Enterohaemorrhagic Escherichia Coli O104:H4 Induced Haemolytic Uraemic Syndrome: Case-Control Study

British Medical Journal - United Kingdom
doi 10.1136/bmj.e4565
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

The Health Implication of Enterohaemorrhagic Escherichia Coli (EHEC) 0157:H7: A Review on Haemolytic Uraemic Syndrome

Asian Journal of Research in Medical and Pharmaceutical Sciences
2019English

Shiga Toxin–Producing Escherichia Coli O104:H4

Infectious Disease Clinics of North America
Infectious DiseasesMicrobiology
2013English

Bloody Coli: A Gene Cocktail in Escherichia Coli O104:H4

mBio
VirologyMicrobiology
2013English

Haemolytic Uraemic Syndrome Associated With Non Shiga Toxin-Producing Escherichia Coli Bacteraemia: A Case Report

BMC Nephrology
Nephrology
2019English

Haemolytic Uraemic Syndrome

The Lancet
Medicine
1984English

Effective Treatment of Chemotherapy Induced Atypical Haemolytic Uraemic Syndrome: A Case Series of 7 Treated Patients

British Journal of Haematology
Hematology
2017English

Genomic Diversity of the 2011 European Outbreaks of Escherichia Coli O104:H4

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Sequelae of Haemolytic Uraemic Syndrome.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1992English

Familial Haemolytic Uraemic Syndrome.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy